GWI Secures Choline DL-Bitartrate Supply

LA MIRADA, Calif.—GWI signed an exclusive partnership with Jinan Asia Pharmaceutical Co. Ltd to secured a continuous supply of uncoated, food-grade choline DL-bitartrate for the United States market. During the past three years, Jinan Asia held 40 percent of the U.S. choline DL-bitartrate market with 60 percent of its quantity being sold through GWI.

Choline is a popular brain health ingredient that has shown to help improve fetal brain development, as well as reduce the symptoms on Cystic Fibrosis in children.  

“Exclusivity always secures the supply for our customers while keeping quality and manufacturer origin consistent," said Jim Schultz, CEO and founder of GWI. "That guarantees the transparency and traceability of all our materials."

According to U.S. customs, the 2013 annual U.S. choline bitartrate import reached 800 MT—a double-digit growth during the last three years. Learn more about the cognitive health market in INSIDER's Digital Issue "Keep Calm and Supplement."

Besides choline DL-bitratrate, GWI also distributes other Jinan Asia products, such as choline L-bitartrate, choline bitartrate coated grade, choline dihydrogen citrate, DMAE and betaine HCL.